In collaboration with Small Bone Innovations (SBi), Artimplant has developed a new product in the Artelon® Spacer range with a similar user-friendly textile design to Artelon® Tissue Reinforcement (ATR). The product, Artelon® CMC Soft, has been granted CE-approval by the certification body Lloyd's and has thus been granted clearance for marketing in Europe.

The major difference between the old Artelon® CMC Spacer and the new Artelon® CMC Soft is that the size can be adjusted and can thus be adapted to the requirements of each individual patient. Artimplant estimates that Artelon® CMC Soft will gradually replace existing Spacer products for thumb base osteoarthritis in the CMC-joint.

About Artimplant

Artimplant's mission is to restore the health of patients by offering medical professionals degradable implants that help the body to heal. Artimplant is a medical device company that restores health through the development, production and marketing of degradable implants that regenerate body functions and improve quality of life. Our products are made from Artelon®, a biomaterial developed by the Company. Artimplant's implants are used for the treatment of osteoarthritis and the reinforcement of weakened soft tissue. The Company's products are sold through licensees and own sales under the Artimplant brand take place through agents and distributors. Artimplant is a public company listed on the NASDAQ OMX Stockholm Exchange in the Small Cap segment and in the Healthcare sector.